New Findings: What is the central question of this study? What are the effects of the antifibrotic peptide acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) on the angiotensin-converting enzyme 2 (ACE2)-angiotensin-(1-7)-Mas axis during the occurrence and progression of silicosis? What is the main finding and its importance? Ac-SDKP inhibited lung fibrosis in rats exposed to silica by activation of the ACE2-angiotensin-(1-7)-Mas axis. Angiotensin-(1-7) potentially promotes Ac-SDKP by increasing the level of meprin α, the major synthetase of Ac-SDKP. Thus, the interaction Ac-SDKP and angiotesin-(1-7) in silicosis could provide a new therapeutic strategy.
Abstract: The central role of angiotensin-converting enzyme (ACE) in the occurrence and progression of silicosis has been established. The antifibrotic peptide acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) can be degraded by ACE. The ACE2-angiotensin-(1-7)-Mas axis is protective and acts to counterbalance the detrimental effects of ACE-angiotensin II (Ang II)-Ang II type 1 receptor and exerts antifibrotic effects. Here, we demonstrate an interaction between Ac-SDKP and Ang-(1-7) in the inhibition of collagen deposition and myofibroblast differentiation in rats exposed to silica. Treatment with Ac-SDKP increased the level of ACE2-Ang-(1-7)-Mas in rats or in cultured fibroblasts and decreased the levels of collagen type I and α-smooth muscle actin. Furthermore, exogenous Ang-(1-7) had similar antifibrotic effects and increased the level of meprin α, a major Ac-SDKP synthetase, both in vivo and in vitro. Compared with non-silicotic patients exposed to silica, the level of serum ACE was increased in patients with silicosis phase III; the levels of Ang II and Ang-(1-7) were high in patients with silicosis phase II; and the level of Ac-SDKP was high in the silicosis phase III group. These data imply that Ac-SDKP and Ang-(1-7) have an interactive effect as regulatory peptides of the renin-angiotensin system and exert antifibrotic effects.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1113/EP087515 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis.
Cancer Res
November 2024
Zhongshan Hospital, Shanghai, Shanghai, China.
Article Synopsis
- Anti-PD-L1 combination immunotherapy is the first-line treatment for unresectable hepatocellular carcinoma (HCC), but its effectiveness is limited, with less than 40% of patients responding.
- Research found that nonresponders had higher activation of the renin-angiotensin system and lower ACE2 expression, which is linked to HCC progression and resistance to treatment.
- Targeting the ACE2 axis may improve responses to anti-PD-L1 therapy by reducing immunosuppressive factors in the tumor environment, positioning it as both a potential therapeutic target and a biomarker for predicting treatment success.
Myocardial Angiotensin-Converting Enzyme 2 Protein Expression in Ischemic Heart Failure.
Int J Mol Sci
December 2023
Laboratory of Cardiac Pathology, Institute of Cardiology, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania.
The angiotensin-converting enzyme 2 (ACE2)-angiotensin-(1-7)-Mas receptor axis plays a significant role in regulating myocardial remodeling and the development of heart failure (HF), with ACE2 being the primary focus. However, contemporary understanding of the membrane-bound form of the human ACE2 protein remains insufficient. The purpose of this study was to determine the expression of ACE2 protein in different cells of the left ventricular myocardium in non-diseased hearts and at various stages of ischemic HF.
View Article and Find Full Text PDFAngiotensin-(1-7) attenuates SARS-CoV2 spike protein-induced interleukin-6 and interleukin-8 production in alveolar epithelial cells through activation of Mas receptor.
J Microbiol Immunol Infect
December 2023
School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC; Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC. Electronic address:
Background: SARS-CoV-2 spike proteins (SP) can bind to the human angiotensin-converting enzyme 2 (ACE2) in human pulmonary alveolar epithelial cells (HPAEpiC) and trigger an inflammatory process. Angiotensin-(1-7) may have an anti-inflammatory effect through activation of Mas receptor. This study aims to investigate whether SARS-CoV-2 SP can induce inflammation through ACE2 in the alveolar epithelial cells which can be modulated through angiotensin-(1-7)/Mas receptor axis.
View Article and Find Full Text PDFRenin-angiotensin system inhibitors mitigate radiation pneumonitis by activating ACE2-angiotensin-(1-7) axis via NF-κB/MAPK pathway.
Sci Rep
May 2023
Department of Oncology, Central Hospital Affiliated to Shandong First Medical University, Jinan, 250013, Shandong, China.
Article Synopsis
- Radiation pneumonitis (RP) is a common issue for lung cancer patients undergoing radiation therapy, with no existing effective treatments to improve outcomes.
- The study explores the role of angiotensin-converting enzyme 2 (ACE2) in RP, finding that enhancing ACE2 expression can reduce lung injury in mice and that specific medications (captopril and valsartan) activate ACE2 and lessen RP effects.
- A review of patients showed that those taking renin-angiotensin system inhibitors (RASis) experienced significantly lower rates of RP compared to those not on these medications, indicating potential for RASis as new treatment options for RP.
Angiotensin-converting enzyme 2 improves hepatic insulin resistance by regulating GABAergic signaling in the liver.
J Biol Chem
December 2022
Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address:
The angiotensin-converting enzyme 2 (ACE2)/angiotensin 1-7/MAS axis and the gamma-aminobutyric acid (GABA)ergic signaling system have both been shown to have the dual potential to improve insulin resistance (IR) and hepatic steatosis associated with obesity in the liver. Recent studies have demonstrated that ACE2 can regulate the GABA signal in various tissues. Notwithstanding this evidence, the functional relationship between ACE2 and GABA signal in the liver under IR remains elusive.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!